{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:11:35Z","timestamp":1792555895597,"version":"4.5.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Increased IFN\u03b1 is important in the pathogenesis of SLE. Plasmacytoid dendritic cells are considered the main producer of IFN\u03b1 upon Toll-like receptor pathway activation. However, which cells produce IFN\u03b1 following stimulation with cyclic GMP-AMP synthase (cGAS) and stimulator of IFN genes (STING) in SLE remains unknown. We investigated the IFN\u03b1 producing capacity of myeloid cells under cGAS-STING pathway stimulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>IFN\u03b1 levels in peripheral blood mononuclear cells from SLE patients and healthy controls stimulated with 2\u20323\u2032c-GAMP, a stimulator of cGAS-STING, were measured by intracellular cytokine staining and flow cytometry. STING expression and its co-localization with TBK1 were examined by flow cytometry or confocal microscopy. The effects of in vitro exposure to IFN\u03b1 on IFN\u03b1 production and STING expression, and in vitro rapamycin treatment on IFN\u03b1 production and STING, pTBK1 and IRF3 expression were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IFN\u03b1 was produced by monocytes, conventional dendritic cells and plasmacytoid dendritic cells upon cGAS-STING pathway activation. The frequency of IFN\u03b1-producing monocytes positively correlated with SLE disease activity. STING expression and its co-localization with TBK1 were increased in lupus monocytes. Prior exposure to IFN\u03b1 enhanced the IFN\u03b1-producing capacity of monocytes. Inhibition of the mechanistic target of the rapamycin (mTOR) pathway suppressed IFN\u03b1 production from monocytes and downregulated enhanced STING expression and its downstream molecules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Enhanced IFN\u03b1 from lupus monocytes induced by augmented STING pathway activation is associated with SLE pathogenesis. Suppression of the mTOR pathway downregulated the enhanced STING expression and the subsequent IFN\u03b1 production by monocytes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa060","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T07:09:17Z","timestamp":1580713757000},"page":"2992-3002","source":"Crossref","is-referenced-by-count":67,"title":["Inhibition of mTOR suppresses IFN\u03b1 production and the STING pathway in monocytes from systemic lupus erythematosus patients"],"prefix":"10.1093","volume":"59","author":[{"given":"Goh","family":"Murayama","sequence":"first","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"},{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Kuga","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"},{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2020092423555333000_keaa060-B1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smim.2011.01.009","article-title":"The type I interferon system in the development of lupus","volume":"23","author":"R\u00f6nnblom","year":"2011","journal-title":"Semin Immunol"},{"key":"2020092423555333000_keaa060-B2","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"2020092423555333000_keaa060-B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","article-title":"Immune interferon in the circulation of patients with autoimmune disease","volume":"301","author":"Hooks","year":"1979","journal-title":"N Engl J Med"},{"key":"2020092423555333000_keaa060-B4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/art.1780250407","article-title":"Serum interferon levels in patients with systemic lupus erythematosus","volume":"25","author":"Ytterberg","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"key":"2020092423555333000_keaa060-B6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.23619","article-title":"Age- and sex-related patterns of serum interferon-\u03b1 activity in lupus families","volume":"58","author":"Niewold","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"2020092423555333000_keaa060-B8","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020092423555333000_keaa060-B9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/08916930310001625952","article-title":"Microarray analysis of interferon-regulated genes in SLE","volume":"36","author":"Crow","year":"2003","journal-title":"Autoimmunity"},{"key":"2020092423555333000_keaa060-B10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.gene.6363966","article-title":"Analysis of gene expression pro\ufb01les in human systemic lupus erythematosus using oligonucleotide microarray","volume":"4","author":"Han","year":"2003","journal-title":"Genes Immun"},{"key":"2020092423555333000_keaa060-B11","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-\u03b1-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-\u03b1 pathway identifies \u03b1 subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B13","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.4049\/jimmunol.174.5.2499","article-title":"IFN-\u03b1 induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB\/c mice","volume":"174","author":"Mathian","year":"2005","journal-title":"J Immunol"},{"key":"2020092423555333000_keaa060-B14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor de\ufb01ciency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J Exp Med"},{"key":"2020092423555333000_keaa060-B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-8411(02)00109-9","article-title":"Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice","volume":"20","author":"Braun","year":"2003","journal-title":"J Autoimmun"},{"key":"2020092423555333000_keaa060-B16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","article-title":"Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors","volume":"115","author":"R\u00f6nnblom","year":"1991","journal-title":"Ann Intern Med"},{"key":"2020092423555333000_keaa060-B17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/art.1780360224","article-title":"Appearance of anti-DNA antibodies in patients treated with interferon-\u03b1","volume":"36","author":"Ehrenstein","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/qjmed\/91.6.393","article-title":"Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon","volume":"91","author":"K\u00e4lkner","year":"1998","journal-title":"QJM"},{"key":"2020092423555333000_keaa060-B19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2020092423555333000_keaa060-B20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"2020092423555333000_keaa060-B21","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J Clin Invest"},{"key":"2020092423555333000_keaa060-B22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.40002","article-title":"Expression of cyclic GMP-AMP synthase in patients with systemic lupus erythematosus","volume":"69","author":"An","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020092423555333000_keaa060-B23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med"},{"key":"2020092423555333000_keaa060-B24","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"2020092423555333000_keaa060-B25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"2020092423555333000_keaa060-B26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"2020092423555333000_keaa060-B27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-\u03b1 production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"L\u00f6vgren","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J Exp Med"},{"key":"2020092423555333000_keaa060-B29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"15","author":"Means","year":"2005","journal-title":"J Clin Invest"},{"key":"2020092423555333000_keaa060-B30","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/art.21893","article-title":"Induction of interferon-\u03b1 by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sj\u00f6gren\u2019s syndrome autoantigen-associated RNA","volume":"54","author":"L\u00f6vgre","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-017-1441-7","article-title":"Enhanced IFN-\u03b1 production is associated with increased TLR7 retention in the lysosomes of plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"19","author":"Murayama","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2020092423555333000_keaa060-B32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signalling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"2020092423555333000_keaa060-B33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coi.2017.04.005","article-title":"mTOR signalling in the differentiation and function of regulatory and effector T cells","volume":"46","author":"Zeng","year":"2017","journal-title":"Curr opin Immunol"},{"key":"2020092423555333000_keaa060-B34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/ni.1645","article-title":"Toll-like receptor- mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTRO-p70S6K pathway","volume":"9","author":"Cao","year":"2008","journal-title":"Nat Immunol"},{"key":"2020092423555333000_keaa060-B35","doi-asserted-by":"crossref","first-page":"e97858","DOI":"10.15252\/embj.201797858","article-title":"Attenuation of cGAS-STING signalling is mediated by a p62\/SQSTM1-dependent autophagy pathway activated by TBK1","volume":"37","author":"Prabakaran","year":"2018","journal-title":"EMBO J"},{"key":"2020092423555333000_keaa060-B36","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-1 in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"2020092423555333000_keaa060-B37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0961203308090020","article-title":"The innate immune system in SLE: type I interferons and dendritic cells","volume":"17","author":"Ronnblom","year":"2008","journal-title":"Lupus"},{"key":"2020092423555333000_keaa060-B38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-017-1257-5","article-title":"Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus","volume":"19","author":"Chiba","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2020092423555333000_keaa060-B39","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/art.40576","article-title":"Association of abnormal elevations in IFIT3 with overactive cyclic GMP-AMP synthase\/stimulator of interferon genes signaling in human systemic lupus erythematosus monocytes","volume":"70","author":"Wang","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020092423555333000_keaa060-B40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.celrep.2018.09.001","article-title":"IFN\u03b1 impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion","volume":"25","author":"Gkirtzimanaki","year":"2018","journal-title":"Cell Rep"},{"key":"2020092423555333000_keaa060-B41","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1073\/pnas.1420217112","article-title":"Suppression of systemic autoimmunity by the innate immune adaptor STING","volume":"112","author":"Sharma","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020092423555333000_keaa060-B42","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.173.3.2134","article-title":"Type I IFN protects against murine lupus","volume":"173","author":"Hron","year":"2004","journal-title":"J Immnunol"},{"key":"2020092423555333000_keaa060-B43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2020092423555333000_keaa060-B44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/art.1780370219","article-title":"Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus","volume":"37","author":"Warner","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B45","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T-cell activation -induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020092423555333000_keaa060-B46","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"2020092423555333000_keaa060-B47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"2020092423555333000_keaa060-B48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"2020092423555333000_keaa060-B49","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni.1939","article-title":"The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells","volume":"11","author":"Liu","year":"2010","journal-title":"Nat Immunol"},{"key":"2020092423555333000_keaa060-B50","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2010.11.024","article-title":"An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness","volume":"33","author":"Procaccini","year":"2010","journal-title":"Immunity"},{"key":"2020092423555333000_keaa060-B51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"2020092423555333000_keaa060-B52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 coupes immune signals and metabolic programming to establish Treg-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"2020092423555333000_keaa060-B53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"2020092423555333000_keaa060-B54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2009.10.010","article-title":"The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and eomesodermin","volume":"32","author":"Rao","year":"2010","journal-title":"Immunity"},{"key":"2020092423555333000_keaa060-B55","first-page":"427","article-title":"Rapamycin unbalances the polarization of human macrophages to M1","volume":"70","author":"Mercalli","year":"2018","journal-title":"Immunology"},{"key":"2020092423555333000_keaa060-B56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Chul","year":"2015","journal-title":"J Clin Invest"},{"key":"2020092423555333000_keaa060-B57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2992\/33790444\/keaa060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2992\/33790444\/keaa060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:01:59Z","timestamp":1600992119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/2992\/5803187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa060","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,3,11]]}}}